Maes, Michael <br/><br/>
New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors.  [electronic resource] 

 -  Inflammopharmacology  Jun 2012 
 - 127-50 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1568-5608 
<br/><br/><label>Standard No.: </label>10.1007/s10787-011-0111-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antioxidants--administration & dosage<br/>Depression--drug therapy<br/>Disease Progression<br/>Drug Delivery Systems--methods<br/>Glycogen Synthase Kinase 3--antagonists & inhibitors<br/>Humans<br/>Immunity, Cellular--drug effects<br/>Inflammation Mediators--antagonists & inhibitors<br/>Mitochondria--drug effects<br/>NF-E2-Related Factor 2--agonists<br/>Nitrosation--drug effects<br/>Oxidative Stress--drug effects